GlassScriptPhysician profile
Katherine A Bohnert
NPI 1235440140
$1,068.30
in general payments reported to CMS, 2019-2025
20 companies · $18.01 in 2025
The $18.01 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.94 · 2020: $366 · 2021: $151 · 2022: $169 · 2023: $161 · 2024: $121 · 2025: $18.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $300.00 | 2020 | |
| Mayne Pharma Commercial LLC | $135.66 | 2021-2024 | |
| Abbvie INC. | $98.41 | 2019-2024 | |
| Organon LLC | $62.97 | 2022-2024 | Nexplanon |
| Coopersurgical, INC. | $61.88 | 2019-2024 | Paragard T 380a |
| Therapeuticsmd, INC. | $58.23 | 2019-2021 | |
| Lupin INC. | $54.01 | 2020-2021 | |
| Daiichi Sankyo INC. | $47.43 | 2021-2023 | Injectafer |
| Innovation Technologies INC | $42.75 | 2024 | Irrisept |
| Sumitomo Pharma America, INC. | $33.53 | 2023 | Myfembree |
| Evofem Biosciences, INC. | $29.58 | 2022 | |
| Exeltis, USA INC. | $27.00 | 2020-2022 | |
| Lilly USA, LLC | $18.01 | 2025 | Zepbound, Mounjaro |
| Ethicon US, LLC | $17.28 | 2022 | |
| Ascend Therapeutics US, LLC | $16.05 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.58 | 2019 | |
| Merck Sharp & Dohme LLC | $14.50 | 2019 | |
| Myovant Sciences INC. | $14.46 | 2022 | |
| Ibsa Pharma INC. | $13.08 | 2023 | Tirosint, Licart |
| Channel Medsystems, INC. | $8.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Bohnert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.